Reliefband, a wearable, effective and drug-free solution for nausea, retching and vomiting, announces a distribution partnership with AmerisourceBergen, a leader in global pharmaceutical sourcing and distribution services. The partnership enables AmerisourceBergen to provide Reliefband products to healthcare providers and retail pharmacies across the U.S.
Approximately 10 percent of the population suffers from motion sickness on a monthly basis, with 5 percent suffering more than once a week. “Today’s healthcare environment necessitates a partner that has the size, reach, and scale to deliver a product to patients at the right time,” says Nick Spring, CEO of Reliefband Technologies. “This new relationship will significantly strengthen and grow our business, increasing our ability to provide innovative solutions to our customers.”
AmerisourceBergen, with more than $145 billion in annual revenue, and a rank of No. 11 on the Fortune 500, is improving product access and transforming the healthcare supply chain daily. Powered by 20,000 associates, AmerisourceBergen is well equipped to provide customers with the safest, most secure and efficient distribution system in healthcare. Through AmerisourceBergen’s Good Neighbor Pharmacy Program, a network of independent community pharmacies, the clinically proven Reliefband technology will be available over-the-counter to everyone needing motion sickness and morning sickness relief.
The Reliefband device is worn on the underside of the wrist, and uses the body’s own neural pathways to naturally regulate the mechanisms causing nausea without drugs. When activated, the Reliefband device emits gentle pulses through the skin stimulating the median nerve at the P6 pressure point located on the underside of the wrist.
This stimulation generates a signal that travels through the body’s central nervous system to the higher emetic center of the brain. The signals modulate the neural pathways between the brain and the stomach, via the vagus nerve to relieve nausea.
This hospital tested and clinically proven therapy works as well as a leading prescription anti-emetic medication, without side effects such as drowsiness or constipation.
Reliefband®, the wearable, effective and drug-free solution for nausea, retching and vomiting announces a distribution partnership with AmerisourceBergen, a leader in global pharmaceutical sourcing and distribution services. The partnership enables AmerisourceBergen to provide Reliefband products to healthcare providers and retail pharmacies across the U.S.
Approximately 10 percent of the population suffers from motion sickness on a monthly basis, with 5 percent suffering more than once a week. “Today’s healthcare environment necessitates a partner that has the size, reach and scale to deliver a product to patients at the right time,” says Nick Spring, CEO of Reliefband Technologies. “This new relationship will significantly strengthen and grow our business, increasing our ability to provide innovative solutions to our customers.”
AmerisourceBergen, with more than $145 billion in annual revenue, and a rank of No. 11 on the Fortune 500, is improving product access and transforming the healthcare supply chain daily. Powered by 20,000 associates, AmerisourceBergen is well equipped to provide customers with the safest, most secure and efficient distribution system in healthcare.
Through AmerisourceBergen’s Good Neighbor Pharmacy Program, a network of independent community pharmacies, the clinically proven Reliefband technology will be available over-the-counter to everyone needing motion sickness and morning sickness relief.
The Reliefband device is worn on the underside of the wrist, and uses the body’s own neural pathways to naturally regulate the mechanisms causing nausea without drugs. When activated, the Reliefband device emits gentle pulses through the skin stimulating the median nerve at the P6 pressure point located on the underside of the wrist.
This stimulation generates a signal that travels through the body’s central nervous system to the higher emetic center of the brain. The signals modulate the neural pathways between the brain and the stomach, via the vagus nerve to relieve nausea.
This hospital tested and clinically proven therapy works as well as a leading prescription anti-emetic medication, without side effects such as drowsiness or constipation.
(Source: Reliefband Technologies LLC)
